Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment

Azithromycin protects mice against ischemic stroke injury by promoting macrophage transition towards M2 phenotype

(2016) Diana Amantea et al.   EXPERIMENTAL NEUROLOGY

Brain trauma elicits non-canonical macrophage activation states

(2016) Charles C. Kim et al.   Journal of Neuroinflammation

Age increases reactive oxygen species production in macrophages and potentiates oxidative damage after spinal cord injury

(2016) Bei Zhang et al.   NEUROBIOLOGY OF AGING

Call Off the Dog(ma): M1/M2 Polarization Is Concurrent following Traumatic Brain Injury

(2016) Josh M. Morganti et al.   PLoS One

Macrophage activation and its role in repair and pathology after spinal cord injury

(2015) John C. Gensel et al.   BRAIN RESEARCH

Age decreases macrophage IL-10 expression: Implications for functional recovery and tissue repair in spinal cord injury

(2015) Bei Zhang et al.   EXPERIMENTAL NEUROLOGY

Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury

(2015) Bei Zhang et al.   Journal of Neuroinflammation

Toll-Like Receptors and Dectin-1, a C-Type Lectin Receptor, Trigger Divergent Functions in CNS Macrophages

(2015) J. C. Gensel et al.   JOURNAL OF NEUROSCIENCE

Neuroprotective effects of pretreatment with macrolide antibiotics on cerebral ischemia reperfusion injury

(2015) Toshiki Inaba et al.   NEUROLOGICAL RESEARCH

Novel Markers to Delineate Murine M1 and M2 Macrophages

(2015) Kyle A. Jablonski et al.   PLoS One

Cell-Type-Specific Jumonji Histone Demethylase Gene Expression in the Healthy Rat CNS: Detection by a Novel Flow Cytometry Method

(2014) Stephanie M.C. Smith et al.   ASN Neuro

Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge

(2014) V Balloy et al.   BRITISH JOURNAL OF PHARMACOLOGY

Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines

(2014) Peter J. Murray et al.   IMMUNITY

IL-4 Signaling Drives a Unique Arginase+/IL-1 + Microglia Phenotype and Recruits Macrophages to the Inflammatory CNS: Consequences of Age-Related Deficits in IL-4R  after Traumatic Spinal Cord Injury

(2014) A. M. Fenn et al.   JOURNAL OF NEUROSCIENCE

TNF and Increased Intracellular Iron Alter Macrophage Polarization to a Detrimental M1 Phenotype in the Injured Spinal Cord

(2014) Antje Kroner et al.   NEURON

Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial

(2014) Sevim Uzun et al.   Lancet Respiratory Medicine

Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis

(2013) Theodore J. Cory et al.   Journal of Cystic Fibrosis

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

(2013) Veronique E Miron et al.   NATURE NEUROSCIENCE

Managing Inflammation after Spinal Cord Injury through Manipulation of Macrophage Function

(2013) Yi Ren et al.   NEURAL PLASTICITY

Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin

(2012) Mario Matijašić et al.   PHARMACOLOGICAL RESEARCH

Azithromycin distinctively modulates classical activation of human monocytes in vitro

(2011) M Vrančić et al.   BRITISH JOURNAL OF PHARMACOLOGY

Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis

(2011) Andrea Mencarelli et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Azithromycin in periodontal treatment: more than an antibiotic

(2011) R. Hirsch et al.   JOURNAL OF PERIODONTAL RESEARCH

Providers' beliefs and behaviors regarding antibiotic prescribing and antibiotic resistance in persons with spinal cord injury or disorder

(2011) Charlesnika T. Evans et al.   JOURNAL OF SPINAL CORD MEDICINE

Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection

(2011) P.S. Franco et al.   PLACENTA

Azithromycin Alters Macrophage Phenotype and Pulmonary Compartmentalization during Lung Infection with Pseudomonas

(2010) D. J. Feola et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Macrophages Promote Axon Regeneration with Concurrent Neurotoxicity

(2009) J. C. Gensel et al.   JOURNAL OF NEUROSCIENCE

Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord

(2009) K. A. Kigerl et al.   JOURNAL OF NEUROSCIENCE

An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology

(2009) Dustin J. Donnelly et al.   JOURNAL OF NEUROSCIENCE METHODS

Azithromycin alters macrophage phenotype

(2008) B. S. Murphy et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Another Barrier to Regeneration in the CNS: Activated Macrophages Induce Extensive Retraction of Dystrophic Axons through Direct Physical Interactions

(2008) K. P. Horn et al.   JOURNAL OF NEUROSCIENCE